These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18413573)

  • 1. PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype.
    Ning YP; Kanai K; Tomiyama H; Li Y; Funayama M; Yoshino H; Sato S; Asahina M; Kuwabara S; Takeda A; Hattori T; Mizuno Y; Hattori N
    Neurology; 2008 Apr; 70(16 Pt 2):1491-3. PubMed ID: 18413573
    [No Abstract]   [Full Text] [Related]  

  • 2. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.
    Di Fonzo A; Chien HF; Socal M; Giraudo S; Tassorelli C; Iliceto G; Fabbrini G; Marconi R; Fincati E; Abbruzzese G; Marini P; Squitieri F; Horstink MW; Montagna P; Libera AD; Stocchi F; Goldwurm S; Ferreira JJ; Meco G; Martignoni E; Lopiano L; Jardim LB; Oostra BA; Barbosa ER; ; Bonifati V
    Neurology; 2007 May; 68(19):1557-62. PubMed ID: 17485642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Juvenile dystonia-parkinsonism syndrome caused by a novel p.S941Tfs1X ATP13A2 (PARK9) mutation.
    Martino D; Melzi V; Franco G; Kandasamy N; Monfrini E; Di Fonzo A
    Parkinsonism Relat Disord; 2015 Nov; 21(11):1378-80. PubMed ID: 26421390
    [No Abstract]   [Full Text] [Related]  

  • 4. From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations.
    Erro R; Picillo M; Manara R; Pellecchia MT; Barone P
    Parkinsonism Relat Disord; 2019 Aug; 65():272-273. PubMed ID: 31151786
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.
    Santoro L; Breedveld GJ; Manganelli F; Iodice R; Pisciotta C; Nolano M; Punzo F; Quarantelli M; Pappatà S; Di Fonzo A; Oostra BA; Bonifati V
    Neurogenetics; 2011 Feb; 12(1):33-9. PubMed ID: 20853184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP13A2-related juvenile-onset Parkinson disease.
    Suleiman J; El-Hattab AW
    Brain Dev; 2019 Feb; 41(2):223. PubMed ID: 30144971
    [No Abstract]   [Full Text] [Related]  

  • 7. ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease.
    Suleiman J; Hamwi N; El-Hattab AW
    Brain Dev; 2018 Oct; 40(9):824-826. PubMed ID: 29903538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kufor-Rakeb Syndrome/PARK9: One Novel and One Possible Recurring Ashkenazi ATP13A2 Mutation.
    Inzelberg R; Estrada-Cuzcano A; Laitman Y; De Vriendt E; Friedman E; Jordanova A
    J Parkinsons Dis; 2018; 8(3):399-403. PubMed ID: 29966207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutation analysis of ATP13A2 gene in Chinese patients with familial autosomal recessive early-onset parkinsonism].
    He D; Guo JF; Wang L; Xiao ZQ; Nie LL; Zhang XW; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Oct; 26(5):567-70. PubMed ID: 19806583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal Storage of Subunit c of Mitochondrial ATP Synthase in Brain-Specific Atp13a2-Deficient Mice.
    Sato S; Koike M; Funayama M; Ezaki J; Fukuda T; Ueno T; Uchiyama Y; Hattori N
    Am J Pathol; 2016 Dec; 186(12):3074-3082. PubMed ID: 27770614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile parkinsonism associated with heterozygous frameshift ATP13A2 gene mutation.
    Fong CY; Rolfs A; Schwarzbraun T; Klein C; O'Callaghan FJ
    Eur J Paediatr Neurol; 2011 May; 15(3):271-5. PubMed ID: 21316993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism.
    Park JS; Mehta P; Cooper AA; Veivers D; Heimbach A; Stiller B; Kubisch C; Fung VS; Krainc D; Mackay-Sim A; Sue CM
    Hum Mutat; 2011 Aug; 32(8):956-64. PubMed ID: 21542062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel ATP13A2 variant causing complicated hereditary spastic paraplegia.
    Zhang F; Liu P; Li J; Cen Z; Luo W
    Neurol Sci; 2024 Apr; 45(4):1749-1753. PubMed ID: 38252374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.
    Kruer MC; Paudel R; Wagoner W; Sanford L; Kara E; Gregory A; Foltynie T; Lees A; Bhatia K; Hardy J; Hayflick SJ; Houlden H
    Neurosci Lett; 2012 Aug; 523(1):35-8. PubMed ID: 22743658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Parkinsonism-Associated Genetic Variations in PARK9 Locus Lead to Functional Impairment of ATPase Type 13A2.
    Park JS; Sue CM
    Curr Protein Pept Sci; 2017; 18(7):725-732. PubMed ID: 26965689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siblings with unusual presentation of early onset Parkinson's disease with dual heterozygous PARK2 and PARK 9 mutation.
    Chatterjee K; Choudhury S; Shubham S; Mondal B; Basu P; Kumar H
    Parkinsonism Relat Disord; 2018 Jul; 52():117-118. PubMed ID: 29606608
    [No Abstract]   [Full Text] [Related]  

  • 17. Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism.
    Podhajska A; Musso A; Trancikova A; Stafa K; Moser R; Sonnay S; Glauser L; Moore DJ
    PLoS One; 2012; 7(6):e39942. PubMed ID: 22768177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia.
    Miranda M; Harmuth F; Bustamante ML; Rossi M; Sturm M; Magnusson ÓT; Bauer P; Klockgether T; Ramirez A
    Parkinsonism Relat Disord; 2020 Dec; 81():45-47. PubMed ID: 33049588
    [No Abstract]   [Full Text] [Related]  

  • 19. ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome.
    Grünewald A; Arns B; Seibler P; Rakovic A; Münchau A; Ramirez A; Sue CM; Klein C
    Neurobiol Aging; 2012 Aug; 33(8):1843.e1-7. PubMed ID: 22296644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.
    Demirsoy S; Martin S; Motamedi S; van Veen S; Holemans T; Van den Haute C; Jordanova A; Baekelandt V; Vangheluwe P; Agostinis P
    Hum Mol Genet; 2017 May; 26(9):1656-1669. PubMed ID: 28334751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.